Cargando…
Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
Non-small cell lung cancer (NSCLC) is reported to have a high incidence rate and is one of the most prevalent types of cancer contributing towards 85% of all incidences of lung cancer. Berberine is an isoquinoline alkaloid which offers a broad range of therapeutical and pharmacological actions again...
Autores principales: | Paudel, Keshav R., Mehta, Meenu, Yin, Geena Hew Suet, Yen, Lee Li, Malyla, Vamshikrishna, Patel, Vyoma K., Panneerselvam, Jithendra, Madheswaran, Thiagarajan, MacLoughlin, Ronan, Jha, Niraj Kumar, Gupta, Piyush Kumar, Singh, Sachin Kumar, Gupta, Gaurav, Kumar, Pradeep, Oliver, Brian G., Hansbro, Philip M., Chellappan, Dinesh Kumar, Dua, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232428/ https://www.ncbi.nlm.nih.gov/pubmed/35171422 http://dx.doi.org/10.1007/s11356-022-19158-2 |
Ejemplares similares
-
Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma
por: Malyla, Vamshikrishna, et al.
Publicado: (2023) -
Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine–Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro
por: Alnuqaydan, Abdullah M., et al.
Publicado: (2022) -
Phytantriol-Based Berberine-Loaded Liquid Crystalline Nanoparticles Attenuate Inflammation and Oxidative Stress in Lipopolysaccharide-Induced RAW264.7 Macrophages
por: Alnuqaydan, Abdullah M., et al.
Publicado: (2022) -
Cytotoxic mechanisms of berberine-phytantriol liquid crystalline nanoparticles against non-small-cell lung cancer
por: Paudel, Keshav Raj, et al.
Publicado: (2023) -
Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases
por: Paudel, Keshav Raj, et al.
Publicado: (2022)